These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 26945352)

  • 1. Adverse Effects of Oral Nonselective and cyclooxygenase-2-Selective NSAIDs on Hospitalization for Acute Kidney Injury: A Nested Case-Control Cohort Study.
    Chou CI; Shih CJ; Chen YT; Ou SM; Yang CY; Kuo SC; Chu D
    Medicine (Baltimore); 2016 Mar; 95(9):e2645. PubMed ID: 26945352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal anti-inflammatory drugs, renin-angiotensin system blockade or diuretics and risk of acute kidney injury: A case-crossover study.
    Weng SE; Hsu WT; Hsiao FY; Lee CM
    Arch Gerontol Geriatr; 2024 Aug; 123():105394. PubMed ID: 38537386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of upper gastrointestinal complications associated with cyclooxygenase-2 selective and nonselective nonsteroidal antiinflammatory drugs.
    Castellsague J; Holick CN; Hoffman CC; Gimeno V; Stang MR; Perez-Gutthann S
    Pharmacotherapy; 2009 Dec; 29(12):1397-407. PubMed ID: 19947799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of new acute myocardial infarction hospitalization associated with use of oral and parenteral non-steroidal anti-inflammation drugs (NSAIDs): a case-crossover study of Taiwan's National Health Insurance claims database and review of current evidence.
    Shau WY; Chen HC; Chen ST; Chou HW; Chang CH; Kuo CW; Lai MS
    BMC Cardiovasc Disord; 2012 Feb; 12():4. PubMed ID: 22297085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonselective and cyclooxygenase-2-selective NSAIDs and acute kidney injury.
    Winkelmayer WC; Waikar SS; Mogun H; Solomon DH
    Am J Med; 2008 Dec; 121(12):1092-8. PubMed ID: 19028206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of hospitalization for upper gastrointestinal adverse events associated with nonsteroidal anti-inflammatory drugs: a nationwide case-crossover study in Taiwan.
    Chang CH; Chen HC; Lin JW; Kuo CW; Shau WY; Lai MS
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):763-71. PubMed ID: 21618340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
    Huang WF; Hsiao FY; Wen YW; Tsai YW
    Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-Converting Enzyme Inhibitor/Receptor Blocker, Diuretic, or Nonsteroidal Anti-inflammatory Drug Use After Major Surgery and Acute Kidney Injury: A Case-Control Study.
    Roberts DJ; Smith SA; Tan Z; Dixon E; Datta I; Devrome A; Hemmelgarn BR; Tonelli M; Pannu N; James MT
    J Surg Res; 2021 Jul; 263():34-43. PubMed ID: 33631376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal safety of nonsteroidal antiinflammatory drugs and selective cyclooxygenase-2 inhibitors in patients on warfarin.
    Cheetham TC; Levy G; Niu F; Bixler F
    Ann Pharmacother; 2009 Nov; 43(11):1765-73. PubMed ID: 19809010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hospitalization for peptic ulcer and bleeding in users of selective COX-2 inhibitors and nonselective NSAIDs with special reference to celecoxib.
    Patterson MK; Castellsague J; Walker AM
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):982-8. PubMed ID: 18711705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: A population-based, nested case-control analysis.
    Schneider V; Lévesque LE; Zhang B; Hutchinson T; Brophy JM
    Am J Epidemiol; 2006 Nov; 164(9):881-9. PubMed ID: 17005625
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative cardiovascular safety of nonsteroidal anti-inflammatory drugs in patients with hypertension: a population-based cohort study.
    Dong YH; Chang CH; Wu LC; Hwang JS; Toh S
    Br J Clin Pharmacol; 2018 May; 84(5):1045-1056. PubMed ID: 29468706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies.
    Ungprasert P; Cheungpasitporn W; Crowson CS; Matteson EL
    Eur J Intern Med; 2015 May; 26(4):285-91. PubMed ID: 25862494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective COX-2 inhibitors, NSAIDs and congestive heart failure: differences between new and recurrent cases.
    McGettigan P; Han P; Jones L; Whitaker D; Henry D
    Br J Clin Pharmacol; 2008 Jun; 65(6):927-34. PubMed ID: 18384446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incremental cost-effectiveness of cyclooxygenase 2-selective versus nonselective nonsteroidal anti-inflammatory drugs in a cohort of coumarin users: a pharmacoeconomic analysis linked to a case-control study.
    Knijff-Dutmer EA; Postma MJ; van der Palen J; Brouwers JR; van de Laar MA
    Clin Ther; 2004 Jul; 26(7):1160-7. PubMed ID: 15336481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined use of nonsteroidal anti-inflammatory drugs with diuretics and/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury.
    Dreischulte T; Morales DR; Bell S; Guthrie B
    Kidney Int; 2015 Aug; 88(2):396-403. PubMed ID: 25874600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of risk profiles for gastrointestinal and cardiovascular adverse effects in nonselective NSAID and COX-2 inhibitor users: a cohort study using pharmacy dispensing data in The Netherlands.
    Layton D; Souverein PC; Heerdink ER; Shakir SA; Egberts AC
    Drug Saf; 2008; 31(2):143-58. PubMed ID: 18217790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of proton pump inhibitors and concomitant drugs with risk of acute kidney injury: a nested case-control study.
    Ikuta K; Nakagawa S; Momo K; Yonezawa A; Itohara K; Sato Y; Imai S; Nakagawa T; Matsubara K
    BMJ Open; 2021 Feb; 11(2):e041543. PubMed ID: 33589451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction.
    Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C
    Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of first- and second-generation cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction.
    Andersohn F; Suissa S; Garbe E
    Circulation; 2006 Apr; 113(16):1950-7. PubMed ID: 16618816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.